Ginkgo Bioworks Holdings (DNA) Return on Invested Capital (2021 - 2023)

Ginkgo Bioworks Holdings (DNA) posted Return on Invested Capital of 3.21% for Q3 2023, up 29.03% on a QoQ basis from 4.53% in Q2 2023.

Ginkgo Bioworks Holdings (DNA) Return on Invested Capital (2021 - 2023) Analysis & Trends

Ginkgo Bioworks Holdings' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 3.21% for Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.00%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.04%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Ginkgo Bioworks Holdings	517.16 Mn	373.30 Mn	16.38 Mn	-

Download Data